Urogen Pharma

URGN

41.0901.58% ( +0.640 )

Closed: Jul 30, 16:00:00 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Urogen Pharma(URGN) predict that the Revenue is 50.96 M (+151.6%), Beat estimate;the EBIT is -20.26 M (+45.11%), Miss estimate;the EPS is -0.47 (+48.91%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.05B151.60%

0.04B121.29%

+0.01B30.31%

EBITMiss expectations

-0.02B45.11%

-0.02B57.70%

-0.00B12.59%

EPSExceed expectations

-0.4748.91%

-0.481447.67%

+0.01141.24%

Upcoming earnings report - FY2026 Q2 Earning Release

Available dateAug 5, 2026

Estimate Revenue63.54 M

Estimate EBIT-3.542 M

Estimate EPS-0.28

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD